MX9203297A - HUMAN MACROPHAGA MIGRATION INHIBITOR FACTOR. - Google Patents

HUMAN MACROPHAGA MIGRATION INHIBITOR FACTOR.

Info

Publication number: MX9203297A
Authority: MX; Mexico
Prior art keywords: macrophaga; human; migration inhibitor; inhibitor factor; factor
Prior art date: 1989-03-17

Application number

MX9203297A

Other languages

Spanish (es)

Inventor

Steven C Clark

Weishui Weiser

Original Assignee

Genetics Inst

Brigham & Womens Hospital

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-03-17

Filing date

1992-06-25

Publication date

1992-07-01

1992-06-25 Application filed by Genetics Inst, Brigham & Womens Hospital filed Critical Genetics Inst

1992-07-01 Publication of MX9203297A publication Critical patent/MX9203297A/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Gastroenterology & Hepatology (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Toxicology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

MX9203297A 1989-03-17 1992-06-25 HUMAN MACROPHAGA MIGRATION INHIBITOR FACTOR. MX9203297A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US32540889A	1989-03-17	1989-03-17

Publications (1)

Publication Number	Publication Date
MX9203297A true MX9203297A (en)	1992-07-01

Family

ID=23267774

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MX9203297A MX9203297A (en)	1989-03-17	1992-06-25	HUMAN MACROPHAGA MIGRATION INHIBITOR FACTOR.

Country Status (5)

Country	Link
EP (1)	EP0463037A1 (en)
JP (1)	JPH04504111A (en)
CA (1)	CA2050332A1 (en)
MX (1)	MX9203297A (en)
WO (1)	WO1990011301A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5723119A (en) *	1989-07-28	1998-03-03	Schering Corporation	Method for enhancing wound healing/repair with IL-4
US5786168A (en) *	1990-06-04	1998-07-28	Kirin Beer Kabushiki Kaisha	Method for recombinant production of antigen non-specific glycosylation inhibiting factor (GIF)
WO1992014480A1 (en) *	1991-02-22	1992-09-03	Amgen Inc.	Use of gm-csf and g-csf to promote accelerated wound healing
US6774227B1 (en) *	1993-05-17	2004-08-10	Cytokine Pharmasciences, Inc.	Therapeutic uses of factors which inhibit or neutralize MIF activity
US6645493B1 (en) *	1993-05-17	2003-11-11	The Picower Institute For Medical Research	Composition containing anti-MIF antibody
US5650295A (en) *	1995-06-02	1997-07-22	Human Genone Sciences, Inc.	Macrophage migration inhibitory factor-3
SI9400363A (en) *	1994-09-19	1996-08-31	Mozetic Francky Bojana	Human macrophage migration inhibitory factor of nonlymphoid origin, expression of mif in e. coli and purification of recombinant protein
US5910427A (en) *	1995-06-22	1999-06-08	La Jolla Institute For Allergy And Immunology	Antigen non-specific glycosylation inhibiting factor derivatives
US5942253A (en)	1995-10-12	1999-08-24	Immunex Corporation	Prolonged release of GM-CSF
US6268151B1 (en)	2000-01-20	2001-07-31	Isis Pharmaceuticals, Inc.	Antisense modulation of macrophage migration inhibitory factor expression
US20030013122A1 (en) *	2001-03-29	2003-01-16	Bucala Richard J.	Methods and compositions for using MHC class II invariant chain polypeptide as a receptor for macrophage migration inhibitory factor
UY27304A1 (en)	2001-05-24	2002-12-31	Avanir Pharmaceuticals	INHIBITORS OF THE INHIBITOR FACTOR OF MIGRATION OF MACROPHAGES AND METHODS FOR IDENTIFICATION
TW200418829A (en)	2003-02-14	2004-10-01	Avanir Pharmaceutics	Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
JP4578067B2 (en) *	2003-06-06	2010-11-10	宏清水	Topical pharmaceutical composition
JP2008534502A (en)	2005-03-24	2008-08-28	アバニール・ファーマシューティカルズ	Thienopyridinone derivatives as inhibitors of macrophage migration inhibitory factor
EP2748613B1 (en)	2011-10-07	2021-05-05	Baxalta GmbH	Oxmif as a diagnostic marker

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0672158B2 (en) *	1984-05-24	1994-09-14	チバ−ガイギ− アクチエンゲゼルシヤフト	Purified human macrophage migration inhibitory factor
ES2052602T3 (en) *	1986-10-03	1994-07-16	Ciba Geigy Ag	NEW PEPTIDES RELATED TO LYMPHOCINES.

1990
- 1990-03-15 WO PCT/US1990/001355 patent/WO1990011301A1/en not_active Application Discontinuation
- 1990-03-15 JP JP2503914A patent/JPH04504111A/en active Pending
- 1990-03-15 EP EP90904716A patent/EP0463037A1/en not_active Withdrawn
- 1990-03-15 CA CA002050332A patent/CA2050332A1/en not_active Abandoned
1992
- 1992-06-25 MX MX9203297A patent/MX9203297A/en unknown

Also Published As

Publication number	Publication date
CA2050332A1 (en)	1990-09-18
EP0463037A1 (en)	1992-01-02
WO1990011301A1 (en)	1990-10-04
JPH04504111A (en)	1992-07-23

Publication	Publication Date	Title
DK55889D0 (en)	1989-02-07	SUBSTITUTED PYROLS
DE69007630D1 (en)	1994-05-05	Voiding blind.
MX9203297A (en)	1992-07-01	HUMAN MACROPHAGA MIGRATION INHIBITOR FACTOR.
ID996B (en)	1996-10-08	SUBSTITUTED PIRROLUM
DE3581730D1 (en)	1991-03-14	HUMAN TUMORNCROSIS FACTOR.
DE68921689D1 (en)	1995-04-20	Mapping method.
FI853249A0 (en)	1985-08-23	CDNA-KLONER FOER HUMAN ERYTHROPOINT.
DE68916020D1 (en)	1994-07-14	Application method.
KR910011830A (en)	1991-07-30	Halogen substituted phenyl-dioxane
NO900404D0 (en)	1990-01-29	APPLICATOR.
DE68912648D1 (en)	1994-03-10	Construction method.
DK578389A (en)	1990-05-19	SUBSTITUTED OXADIAMINOBUTANES
KR900702433A (en)	1990-12-07	Reference point return method
FR2627799B1 (en)	1990-08-17	OSCILLOBATTANTE WINDOW
FI895903A0 (en)	1989-12-11	ARTIFICIALLY HJAERTA.
ATA239788A (en)	1992-01-15	Prefabricated component
IT1234624B (en)	1992-05-25	FINISHED WINDOW.
DE58903542D1 (en)	1993-03-25	CONSTRUCTION PROFILE.
DK429689D0 (en)	1989-08-31	SUBSTITUTED PYRIDAZINONS
DK189289D0 (en)	1989-04-19	SUBSTITUTED THIOUR INGREDIENTS
NO885637D0 (en)	1988-12-20	Curtain.
DE68927224D1 (en)	1996-10-24	Thermostatic units
ATA149789A (en)	1992-04-15	RAILWHEEL
SE8900713D0 (en)	1989-03-02	PREFABRICATED BJAELKLAGSKASSETT
ES1012166Y (en)	1991-02-01	STAIRCASE PEDRAIN PROTECTOR-TRIM.